Circulating MicroRNAs As Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2025 Jan 8

PMID 39766088

Authors

Apriliana Ellya Ratna Kartikasari

Paul Michel-Lara

Hayden Exton

Kaan Tekin-Sari

Ebtesam Motlaq M Alnefai

Arnan Mitchell

Cesar Sanchez-Huertas

Magdalena Plebanski

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer (OC) is one of the most common gynecological cancers [...].

References

Ren X, Zhang H, Cong H, Wang X, Ni H, Shen X . Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer. Pathol Oncol Res. 2018; 24(4):739-744. DOI: 10.1007/s12253-018-0392-x. View

Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H . Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019; 11:287-299. PMC: 6500433. DOI: 10.2147/IJWH.S197604. View

Jeon H, Seo S, Kim T, Ryu J, Kong H, Jang S . Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer. Curr Issues Mol Biol. 2022; 44(1):288-300. PMC: 8928998. DOI: 10.3390/cimb44010021. View

Hannan N, Cohen P, Beard S, Bilic S, Zhang B, Tong S . Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer. Gynecol Oncol Rep. 2022; 39:100894. PMC: 8717717. DOI: 10.1016/j.gore.2021.100894. View

Meany D, Sokoll L, Chan D . Early Detection of Cancer: Immunoassays for Plasma Tumor Markers. Expert Opin Med Diagn. 2009; 3(6):597-605. PMC: 2788950. DOI: 10.1517/17530050903266830. View

Macfarlane L, Murphy P . MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2011; 11(7):537-61. PMC: 3048316. DOI: 10.2174/138920210793175895. View

Mor G, Visintin I, Lai Y, Zhao H, Schwartz P, Rutherford T . Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A. 2005; 102(21):7677-82. PMC: 1140439. DOI: 10.1073/pnas.0502178102. View

Baratloo A, Hosseini M, Negida A, El Ashal G . Part 1: Simple Definition and Calculation of Accuracy, Sensitivity and Specificity. Emerg (Tehran). 2015; 3(2):48-9. PMC: 4614595. View

Chen Z, Guo X, Sun S, Lu C, Wang L . Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses. Bioengineered. 2020; 11(1):311-317. PMC: 7161537. DOI: 10.1080/21655979.2020.1736755. View

10.

Buys S, Partridge E, Black A, Johnson C, Lamerato L, Isaacs C . Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011; 305(22):2295-303. DOI: 10.1001/jama.2011.766. View

11.

Oliveira D, Carlsen A, Heegaard N, Prahm K, Christensen I, Hogdall C . Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass. PLoS One. 2019; 14(11):e0225249. PMC: 6860451. DOI: 10.1371/journal.pone.0225249. View

12.

Niemira M, Erol A, Bielska A, Zeller A, Skwarska A, Chwialkowska K . Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer. Sci Rep. 2023; 13(1):19287. PMC: 10630404. DOI: 10.1038/s41598-023-45317-7. View

13.

Hashimoto K, Inada M, Yamamoto Y, Ochiya T . Preliminary evaluation of miR-1307-3p in human serum for detection of 13 types of solid cancer using microRNA chip. Heliyon. 2021; 7(9):e07919. PMC: 8441074. DOI: 10.1016/j.heliyon.2021.e07919. View

14.

Schwarzenbach H, Nishida N, Calin G, Pantel K . Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014; 11(3):145-56. DOI: 10.1038/nrclinonc.2014.5. View

15.

Kan C, Hahn M, Gard G, Maidens J, Huh J, Marsh D . Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC Cancer. 2013; 12:627. PMC: 3542279. DOI: 10.1186/1471-2407-12-627. View

16.

Gumusoglu-Acar E, Gunel T, Hosseini M, Dogan B, Tekarslan E, Gurdamar B . Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. Oncol Lett. 2023; 25(4):142. PMC: 9996378. DOI: 10.3892/ol.2023.13728. View

17.

Cui M, Wang H, Yao X, Zhang D, Xie Y, Cui R . Circulating MicroRNAs in Cancer: Potential and Challenge. Front Genet. 2019; 10:626. PMC: 6656856. DOI: 10.3389/fgene.2019.00626. View

18.

Zhang A, Hu H . A Novel Blood-Based microRNA Diagnostic Model with High Accuracy for Multi-Cancer Early Detection. Cancers (Basel). 2022; 14(6). PMC: 8946599. DOI: 10.3390/cancers14061450. View

19.

Alles J, Fehlmann T, Fischer U, Backes C, Galata V, Minet M . An estimate of the total number of true human miRNAs. Nucleic Acids Res. 2019; 47(7):3353-3364. PMC: 6468295. DOI: 10.1093/nar/gkz097. View

20.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View